S. 2543, Prescription Drug Pricing Reduction Act: issues related to value-based payment.
Issues related to value-based drug pricing and drug pricing in general.
Issues related to H.R. 2507, Newborn Screening Saves Lives Reauthorization Act of 2019. Issues related to gene therapies, drug pricing, and Bluebird Bio specifically.
Issues related to the Patient Affordability, Value and Efficacy Act (PAVE).
Issues related to H.R. 2296, the METRIC Act.
MMM - Medicare/Medicaid HCR - Health Issues
34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
BLUEBIRD BIO, INC.
455 Grand Union Boulevard, Somerville, MA, 02145, US
MARK BATTAGLINI MARK BATTAGLINI